Medicinal Chemistry III

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Postgraduate Course in Pharmaceutical Medicine A warm welcome to all participants.
Pharmacology for Anesthesia I Introduction. What is a Drug?
بسم الله الرحمن الرحيم. Department of Pharmacy Practice Community Pharmacy [Code: 441]
A 42 year old mother of two, Mrs Jan Jones comes into the pharmacy to fill a repeat prescription for a Ventolin Inhaler..
CHAPTER 10 Basic Biopharmaceutics
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology Dr. Robert L. Patrick Department of Neuroscience Brown University Biomed.
WELCOME EXPERIENCE PHARMACY AT KING’S. Timetable 12:00Introduction 12:15Mini-lectures: Medicines Optimisation |The Science Perspective |The Clinical Perspective.
Anti-hypertensive agents
Mrs Kearns (78 y.o) asks for an antihistamine. She tells you that she used to use Teldane® when she last had this problem.
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
A 34 year old male, Tom enters your pharmacy with his partner, Phil and asks for a cough medicine.
ANTINEOPLASTICS I: GENERAL CONCEPTS
Faculty of Medical Sciences School of Biomedical Sciences Dr Edwin Williams Director of Studies
Marine Drug Development and Delivery Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM ,
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
Group work based assessment in distance learning Dr Clare Sansom, CDE Fellow 20 July 2015.
Fundamentals of Drug Action
PHC 222 Medicinal Chemistry-1- Part(I) Dr. Huda Al Salem Lecture (1)
STUDY GUIDE FOR CHM 102. CHM 102: Introductory Chemistry II Credit Points : 4 Year: 2010/2011 Semester: Harmattan About the Course: This course introduces.
Lecture 6 II. Non-receptor Mechanisms. Direct Physical blocking of channel local anesthetic & amiloride Modulator Bind to the channel protein itself Ca.
Pharmacology UG-Course Touqeer Ahmed PhD 19 th February, 2015 Atta-ur-Rahman School of Applied Biosciences National University of Sciences and Technology.
Developing medicines for the future and why it is challenging Angela Milne.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
Material Science (Code: PE 217 ) Prepared by: Dr. Ehssan Nassef Pharos University in Alexandria Faculty of Engineering. Petrochemical Department.
Introduction to Basic Therapeutics Module
INTRODUCTION. This powerpoint works best only if you are using office Some features of the given presentation may not work if you are using older.
 Biochemistry deals a basic understanding of the chemical compounds and their metabolic processes occurring in the cells/organisms.  Clinical biochemistry.
INTRODUCTION CLINICAL PHARMACOKINETICS
How drugs Act :General principles Lecture 2
PHC 222 MEDICINAL CHEMISTRY -1- Part I. ABOUT THIS COURSE.. No. of Credits: 2 Student Level: 4 th Courses required: PHC 211 Teatchers: 1- Dr. Huda Al-Salem,
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
طه Coordinator : Dr.Mohammad Mansi Co-coordinator: Dr. Samah Metwally.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
KING ABDULAZIZ UNIVERSITY FACULTY OF SCIENCE INSTRUCTOR: D.Maryam AL-Ghamdi COURSE CODE: BIOC 371 OFFICE HOURS:Su,Tu& Thu.
Prof. hanan Hagar.  Identify different targets of drug action Ilos Elaborate on drug binding to receptors Differentiate between their patterns of action;
Pharmaceutical Chemistry II Joseph o. oweta | PHc 3201.
Basic Concepts of Pharmacology © Paradigm Publishing, Inc.
Responses to the student’s evaluation Pharmaceutical Chemistry Department.
Medicinal Chemistry Lecture – I Introduction and Course Overview Joseph O. Oweta B. Pharm (MUST)
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 1: Sections
INTRODUCTION TO BIOCHEMISTRY By Dr. Mohammed Golam Rasul COLLEGE OF DENTISTRY MAJMAAH UNIVERSITY.
5 Pharmacodynamics.
Drug Discovery &Development
Drugs for Hypertension
Toxicology Drug Poisioning.
Prof. Dr. Basavaraj K. Nanjwade M. Pharm., PhD
ION CHANNELS AS DRUG TARGETS & CONTROL OF RECEPTOR EXPRESSION
BTP3822 BIOPHARMACEUTICS by
Understanding the Basics of Pharmacology
An Introduction to Medicinal Chemistry 3/e
Acidity and basicity of Drugs Pharmaceutical Medicinal Chemistry-I
Toxicology Drug Poisioning.
Biopharmaceutics Dr Mohammad Issa Saleh.
Phase-II Drug Metabolism Pharmaceutical Medicinal Chemistry-I
UNIT 2: ANTIHYPERTENSIVE DRUGS
5 Pharmacodynamics.
Phase-I Drug Metabolism Pharmaceutical Medicinal Chemistry-I
Introduction; Scope of Pharmacology Routes of Drug Administration
Clinical Pharmacokinetics
INTRODUCTION to Pharmacology
Advanced Higher Chemistry Unit 3(e)
Clinical Pharmacokinetics
Drug Delivery Systems Pharmaceutical technology Petra University.
Pharmacodynamic Dr. Hashem Mansour.
Adrenergic Acting Drugs Pharmaceutical Medicinal Chemistry-I
Pharmacodynamics i Prof. hanan Hagar.
Objectives To discuss what happens after drug administration
Copyright Notice You are authorized to use these slides subject to the following terms, conditions and exceptions: They are to be used solely for personal,
Presentation transcript:

Medicinal Chemistry III Module Overview B. Pharm., Semester-1 Course Code: 0510411, Session: 2016-2017 Facilitators and Module Coordinators DR. PRAN KISHORE DEB DR. BILAL AL-JAIDI Assistant Professor Faculty of Pharmacy, Philadelphia University, Jordan

Method of Delivery Method of Delivery No. of Activities Lectures 40 Workshops/Tutorials 05 Online Quiz (Kahoot) 15

Lecture Topics No. of Lectures Anticancer agents Alkylating Agents Heavy metal compounds (Metallating Agents) Anti-metabolites and Antibiotics Plant Extracts Topoisomerase inhibitors Combination of chemotherapy with other treatments 15 Diuretics Carbonic Anhydrase Inhibitors (CAIs) Loop Diuretics Thiazide and Thiazide-like Diuretics Potassium-sparing diuretics Osmotic diuretics 06 Respiratory drug development Design and Development of β2- Agonists and Treatment of Asthma 03 Cardiovascular drug development Development of β-blockers Calcium channel blockers Angiotensin converting enzyme inhibitors (ACE inhibitors) Angiotensin II receptor antagonists Direct acting vasodilator 14 Gastric drug development Development of Proton Pump Inhibitors 02 QUIZ-1 QUIZ-2 QUIZ-3

Class aims, objectives and rationale The class relates the structure and function of various proteins, receptors, enzymes and nucleic acids to drug discovery and action and provides a broad overview of the drug discovery and design process. There is particular emphasis on the factors (potency and efficacy, pharmacology and ADMET) that influences structure-activity relationships (SAR) as well as guide the development of small molecules into drug candidates and ultimately into drugs. Case examples from different therapeutic areas such as anti-cancer, cardiovascular, respiratory, diuretics and anti-ulcer agents are used to contextualise this process.

Learning outcomes: Upon the completion of this class, the student will be able to: Explain how protein (receptor, enzymes) and DNA structure relates to function with respect to their role as targets for drug discovery. Describe how active site topology controls specific catalytic processes that require regulation in different therapeutic scenarios. Outline how multidisciplinary scientific considerations during the lead optimisation process combine to produce a successful drug. Explain how knowledge of physicochemical properties in drug development can address problems encountered with formulation, administration, absorption and elimination. Describe how the requirements of drug development vary depending upon the specific target and the therapeutic area. Understand how previous drugs have been successfully developed using case studies that address varied administrative routes within a range of therapeutic areas (for example: anti-cancer agents, cardiovascular; respiratory; diuretics). Show how structural modifications of drugs within these therapeutic areas can be used to alter their pharmacodynamics and pharmacokinetics and overcome other issues (e.g. toxicity, prodrug design).

Assessment Methods Formative Assessment (Practice only, Kahoot Quiz & Tutorials) Summative Assessment (Marks included) Summative Assessment Type questions Duration Marks First Exam MCQs, Fill up the blanks, SAQs 1 hr 20 Second Exam Quizzes (3) Total 3 quizzes will be conducted. Average of the three quizzes will be considered 10 min Final Exam MCQs, SAQs, Fill up the blanks, True-False 2 hrs 40 Total 100

Recommended Books An introduction to Medicinal Chemistry by Graham L. Patrick. Fourth edition, Oxford, 2009. Wilson and Griswold’s Text Book of Organic Medicinal and Pharmaceutical Chemistry by John M. Beale, Jr. and John H. Black, Twelfth edition, Lippincott Williams and Wilkings 2011. Foye’s principle of medicinal chemistry by David H. Williams, Thomas L. Leuke, Williams O. Foye. Lippincot William and Wilkins. Seventh edition, 2012, ISBN.

Good Luck ……..